How sound processing in the ear and brain relates to educational outcomes, mental health, and quality of life in adolescents living with HIV
Project Number2R01HD095277-06
Former Number5R01HD095277-05
Contact PI/Project LeaderBUCKEY, JAY C
Awardee OrganizationDARTMOUTH COLLEGE
Description
Abstract Text
Even with active antiretroviral therapy, some children living with HIV develop neurocognitive deficits and
show neurodevelopmental delays. This can affect their ability to read, form relationships, and find productive
employment. Detecting HIV-associated central nervous system (CNS) effects early, and following their
progress reliably, is critical for studying, assessing, and treating this disabling HIV co-morbidity—particularly in
the lower- and middle- income countries where most cases exist and resources are limited. We have been
tracking literacy development and cognitive performance longitudinally in a cohort of children living with and
without HIV (CLWH/CLWOH) in Dar es Salaam Tanzania. The focus is determining if tests of central auditory
function (i.e., tests of the brain’s ability to process complex sounds) are associated with, or predict, the
development of literacy, behavioral problems, and neurocognitive abilities. Results show that CLWH have
worse neurocognitive performance, poorer literacy skills, and more behavioral problems on average than their
non-infected age and socioeconomic status matched peers. Interestingly, central auditory test performance
correlates with literacy and neurocognitive outcomes. Children who consistently perform better than their peers
in detecting speech in background noise are more likely to read earlier than those who do not. Similarly,
children with poor central auditory performance also have worse performance on cognitive tests of memory,
attention, and processing speed. These results support our previous work showing that performance on tasks
assessing the central auditory system correlate with tests of neurocognitive abilities. These longitudinal results
suggest the tests might be predictive, where a central auditory test at a young age might help predict the
subsequent development of literacy and at a later age. Children entered the current study at ages 3-8, now
they will be entering adolescence. A key question is whether these tests might predict critical life outcomes
such as school performance, mental health, and quality of life. Very few studies exist that follow CLWH into
adolescence when CLWH take more responsibility for their care. This renewal will show how auditory tests
relate to educational outcomes, mental health, and quality of life in a well-studied cohort of CLWH/CLWOH as
they progress into adolescence. We have assembled an international team with experience in central auditory,
neurocognitive, and neuropsychological testing. Dr. Nina Kraus and her team at Northwestern are
internationally recognized experts in auditory electrophysiology. The Dar es Salaam team has extensive
experience in performing both central auditory and neurocognitive tests and managing large-scale studies. Dr.
Jonathan Lichtenstein is expert in assessing neurocognitive function and developmental delays in children.
Together this team will track educational, mental health, and quality of life outcomes in CLWH and determine
the role central auditory testing could play in predicting or assessing the neurocognitive effects of HIV infection.
These tests may offer a new and improved way to assess critical life outcomes in adolescents living with HIV.
Public Health Relevance Statement
Project Narrative
This combined cross-sectional and longitudinal study will show whether central auditory tests could offer
value for assessing or predicting the central nervous system effects of HIV infection in children and
adolescents. Diagnosing and monitoring of central nervous system co-morbidities is essential in HIV infection,
and central auditory tests may offer a simpler, easier to perform way to assess this than current techniques.
This could alter clinical practice if central auditory tests are shown to be useful for screening for or predicting
central nervous system effects in children and adolescents living with HIV in resource-limited settings.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
041027822
UEI
EB8ASJBCFER9
Project Start Date
16-August-2018
Project End Date
31-May-2029
Budget Start Date
01-August-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$834,593
Direct Costs
$631,509
Indirect Costs
$203,084
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$834,593
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01HD095277-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01HD095277-06
Patents
No Patents information available for 2R01HD095277-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01HD095277-06
Clinical Studies
No Clinical Studies information available for 2R01HD095277-06
News and More
Related News Releases
No news release information available for 2R01HD095277-06
History
No Historical information available for 2R01HD095277-06
Similar Projects
No Similar Projects information available for 2R01HD095277-06